Cleared Traditional

K865079 - ASPIRATING NEEDLE

K865079 is the FDA 510(k) clearance for ASPIRATING NEEDLE by Dlp, Inc.. It is a Class 2 Cardiovascular device (product code DWF) cleared through the Traditional 510(k) pathway after a 64-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1987
Decision
64d
Days
Class 2
Risk

K865079 is an FDA 510(k) clearance for the ASPIRATING NEEDLE, CATALOG CODE #12006. Classified as Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (product code DWF), Class II - Special Controls.

Submitted by Dlp, Inc. (Grand Rapids, US). The FDA issued a Cleared decision on March 3, 1987 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dlp, Inc. devices

Submission Details

510(k) Number K865079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 29, 1986
Decision Date March 03, 1987
Days to Decision 64 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 125d · This submission: 64d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass

All 231
Devices cleared under the same product code (DWF) and FDA review panel - the closest regulatory comparables to K865079.
TDMAC-HEPARIN COATED RMI
K870421 · Research Medical, Inc. · May 1987
RMI VENOUS DRAINAGE CANNULA
K870109 · Research Medical, Inc. · Mar 1987
GRUNWALD BI-CAVAL & JONES BI-CAVAL CANNULA
K870507 · Research Medical, Inc. · Mar 1987
RMI FEMORAL VENOUS DRAINAGE CANNULA
K863740 · Research Medical, Inc. · Feb 1987
URESIL CAROTID SHUNT
K863558 · Uresil Corp. · Nov 1986
TDMAC-HEPARIN COATED RMI CAROTID BY-PASS SHUNT
K862634 · Research Medical, Inc. · Oct 1986